PubMed COVID-19 Clinical Care

The infectious disease Covid-19 has been causing severe social, economic, and human suffering across the globe since 2019. The countries have utilized different strategies in the last few years to combat Covid-19 based on their capabilities

No abstract

Through the experiences gained by accelerating new vaccines for both Ebola virus infection and COVID-19 in a public health emergency, vaccine development has benefited from a 'multiple shots on goal' approach to new vaccine targets. This approach

CONCLUSION: These findings suggest that, within the limits of the National Health Interview Survey, mental health outcomes were worse but stable in a socioeconomically disadvantaged demographic between 2019 and 2021. In a higher socioeconomic bracket

The COVID-19 pandemic deeply disrupted all aspects of life for young people in college. Beginning early in the pandemic, research has documented how young people experienced these challenges and the impacts on their psychosocial wellbeing and

No abstract

CONCLUSIONS: Both OSN-qRT-PCR and cdPCR had better performance than qRT-PCR, and CBPH had the highest diagnostic performance in detecting SARS-CoV-2, which contributed the most improvement to the determination of the critical value in gray area

CONCLUSION: COVID-19 vaccination policies should aim for increased vaccine production as well as a rapid and extensive vaccine delivery system to ensure the maximal value of vaccination strategies. These results can aid policymakers in opting for the

The effect of mutations of the catalytic dyad residues of SARS-CoV-2 main protease (MPro^(WT)) on the thermodynamics of binding of covalent inhibitors comprising nitrile [nirmatrelvir (NMV), NBH2], aldehyde (GC373) and ketone (BBH1) warheads to MPro

No abstract